ArticleResearch square2026

Tumor microenvironment changes after treatment with avelumab and immune-stimulating agent combinations in patients with advanced solid tumors.

Nejla Ozirmak Lermi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.